In our oncology focus month, Ryan McGuire takes a look at the impact of clinical development on cancer drug ... phase 1, phase 2 and phase 3 clinical trial." Based on the report's trial data, it ...

Pre-Clinical Drug Discovery Services Market to grow through 2035, driven by rising chronic diseases and increased outsourcing of early-stage R&D.

By embracing a mix of co-innovation and best practices, stakeholders can boost productivity, streamline clinical trials, and ...

Amgen AMGN reported first-quarter 2025 adjusted earnings of $4.90 per share, which beat the Zacks Consensus Estimate of $4.16 ...

The company intended to move the drug into late-stage testing, which is generally the last phase of development before ... more than half the patients in a clinical trial stopped taking it.